Advanced Malignant Melanoma: Immunologic and Multimodal Therapeutic Strategies
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advanced Malignant Melanoma: Immunologic and Multimodal Therapeutic Strategies
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2010, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2010-03-10
DOI
10.1155/2010/689893
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adoptive Transfer of Gene-Modified Primary NK Cells Can Specifically Inhibit Tumor Progression In Vivo
- (2014) H. J. Pegram et al. JOURNAL OF IMMUNOLOGY
- Killer Ig-Like Receptor Expression in Uterine NK Cells Is Biased toward Recognition of HLA-C and Alters with Gestational Age
- (2014) A. M. Sharkey et al. JOURNAL OF IMMUNOLOGY
- Inhibition of Serine-Peptidase Activity Enhances the Generation of a Survivin-Derived HLA-A2-Presented CTL Epitope in Colon-Carcinoma Cells
- (2010) G. Preta et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Treatment combinations targeting apoptosis to improve immunotherapy of melanoma
- (2009) Peter Hersey et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
- (2009) J. Weber et al. CLINICAL CANCER RESEARCH
- Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells
- (2009) Christine Sers et al. INTERNATIONAL JOURNAL OF CANCER
- Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-Dose Interferon Alfa-2b With or Without a Modified High-Dose Interferon Alfa-2b Induction Phase in Patients With Lymph Node–Negative Melanoma
- (2009) Axel Hauschild et al. JOURNAL OF CLINICAL ONCOLOGY
- Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity
- (2009) Caspar Ohnmacht et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism
- (2009) G. V. Shurin et al. JOURNAL OF IMMUNOLOGY
- Autoimmune Antibodies and Recurrence-Free Interval in Melanoma Patients Treated With Adjuvant Interferon
- (2009) Marna G. Bouwhuis et al. JNCI-Journal of the National Cancer Institute
- Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
- (2009) Ramon Kaneno et al. Journal of Translational Medicine
- Vaccine trials in melanoma—time for reflection
- (2009) Alexander M. M. Eggermont Nature Reviews Clinical Oncology
- Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma
- (2009) Emmanuel Seront et al. Recent Patents on Anti-Cancer Drug Discovery
- IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma
- (2008) Klaus Stensgaard Frederiksen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Efficient Identification of a Novel Cancer/Testis Antigen for Immunotherapy Using Three-Step Microarray Analysis
- (2008) T. Yokoe et al. CANCER RESEARCH
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
- (2008) J LOPICCOLO et al. DRUG RESISTANCE UPDATES
- Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma
- (2008) John A. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group
- (2008) Alessandro Testori et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
- (2008) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming
- (2008) D. Atanackovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero
- (2008) J. E. Mold et al. SCIENCE
- “It is the antigen(s), stupid” and other lessons from over a decade of vaccitherapy of human cancer
- (2008) Matthew R. Buckwalter et al. SEMINARS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started